- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Reviewers Acknowledgment
- Submit a Manuscript
- Subscription Information
- Table of Contents
Obstetrics and Gynecology International
Volume 2012 (2012), Article ID 867265, 8 pages
Clinical Features and Correlates of Outcomes for High-Risk, Marginalized Mothers and Newborn Infants Engaged with a Specialist Perinatal and Family Drug Health Service
1School of Psychology, Macquarie University, Sydney, NSW 2113, Australia
2National Drug and Alcohol Research Centre, Faculty of Medicine, University of New South Wales, Sydney, NSW 2052, Australia
3Drug Health Services, Royal Prince Alfred Hospital, Camperdown, NSW 2050, Australia
4Sydney Medical School, Camperdown, NSW 2050, Australia
Received 21 July 2012; Accepted 26 September 2012
Academic Editor: J. L. Simpson
Copyright © 2012 Lee Taylor et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- Australian Institute of Health and Welfare, “Statistics on Drug Use in Australia 2004,” AIHW Drug Statistics Series no. 15, Cat. no. PHE 62, Australian Institute of Health and Welfare, Canberra, Australia, 2005.
- A. El-Mohandes, A. A. Herman, M. N. El-Khorazaty, P. S. Katta, D. White, and L. Grylack, “Prenatal care reduces the impact of illicit drug use on perinatal outcomes,” Journal of Perinatology, vol. 23, no. 5, pp. 354–360, 2003.
- M. O'Donnell, N. Nassar, H. Leonard et al., “Increasing prevalence of neonatal withdrawal syndrome: population study of maternal factors and child protection involvement,” Pediatrics, vol. 123, no. 4, pp. e614–e621, 2009.
- F. Craig, J. Oei, J. Kent-Biggs, and K. Lui, “Drug dependency in pregnancy—a statewide survey of maternity hospitals in NSW,” in Proceedings of the 9th Annual Congress of the Perinatal Society of Australia and New Zealand, p. 32, Adelaide, Australia, 2004.
- L. P. Finnegan, “Treatment issues for opioid-dependent women during the perinatal period,” Journal of Psychoactive Drugs, vol. 23, no. 2, pp. 191–201, 1991.
- G. S. Hagopian, H. M. Wolfe, R. J. Sokol, J. W. Ager, J. N. Wardell, and E. E. Cepeda, “Neonatal outcome following methadone exposure in utero,” Journal of Maternal-Fetal and Neonatal Medicine, vol. 5, no. 6, pp. 348–354, 1996.
- S. E. Gutierres and A. Barr, “The relationship between attitudes toward pregnancy and contraception use among drug users,” Journal of Substance Abuse Treatment, vol. 24, no. 1, pp. 19–29, 2003.
- R. Kennare, A. Heard, and A. Chan, “Substance use during pregnancy: risk factors and obstetric and perinatal outcomes in South Australia,” Australian and New Zealand Journal of Obstetrics and Gynaecology, vol. 45, no. 3, pp. 220–225, 2005.
- A. M. Telsey, T. A. Merrit, and S. D. Dixon, “Cocaine exposure in a term neonate. Necrotizing enterocolitis as a complication,” Clinical Pediatrics, vol. 27, no. 11, pp. 547–550, 1988.
- J. R. Janke, “Prenatal cocaine use. Effects on perinatal outcome,” Journal of Nurse-Midwifery, vol. 35, no. 2, pp. 74–77, 1990.
- K. Johnson, A. Greenough, and C. Gerada, “Maternal drug use and length of neonatal unit stay,” Addiction, vol. 98, no. 6, pp. 785–789, 2003.
- J. P. Ludlow, S. F. Evans, and G. Hulse, “Obstetrics and perinatal outcomes in pregnancies associated with illicit substance abuse,” Australian and New Zealand Journal of Obstetrics and Gynaecology, vol. 44, no. 4, pp. 302–306, 2004.
- M. E. Abdel-Latif, B. Bajuk, K. Lui, and J. Oei, “Short-term outcomes of infants of substance-using mothers admitted to neonatal intensive care units in New South Wales and the Australian Capital Territory,” Journal of Paediatrics and Child Health, vol. 43, no. 3, pp. 127–133, 2007.
- L. Burns, R. P. Mattick, and M. Cooke, “The use of record linkage to examine illicit drug use in pregnancy,” Addiction, vol. 101, no. 6, pp. 873–882, 2006.
- M. Behnke and F. D. Eyler, “The consequences of prenatal substance use for the developing fetus, newborn, and young child,” International Journal of the Addictions, vol. 28, no. 13, pp. 1341–1391, 1993.
- C. D. Coles and K. A. Platzman, “Behavioral development in children prenatally exposed to drugs and alcohol,” International Journal of the Addictions, vol. 28, no. 13, pp. 1393–1433, 1993.
- A. L. Van Baar, S. Soepatmi, W. B. Gunning, and G. W. Akkerhuis, “Development after prenatal exposure to cocaine, heroin and methadone,” Acta Paediatrica, International Journal of Paediatrics, Supplement, vol. 83, no. 404, pp. 40–46, 1994.
- H. C. Steinhausen, B. Blattmann, and F. Pfund, “Developmental outcome in children with intrauterine exposure to substances,” European Addiction Research, vol. 13, no. 2, pp. 94–100, 2007.
- A. Ornoy, J. Segal, R. Bar-Hamburger, and C. Greenbaum, “Developmental outcome of school-age children born to mothers with heroin dependency: importance of environmental factors,” Developmental Medicine and Child Neurology, vol. 43, no. 10, pp. 668–675, 2001.
- D. S. Messinger, C. R. Bauer, A. Das et al., “The maternal lifestyle study: cognitive, motor, and behavioral outcomes of cocaine-exposed and opiate-exposed infants through three years of age,” Pediatrics, vol. 113, no. 6, pp. 1677–1685, 2004.
- R. W. Hunt, D. Tzioumi, E. Collins, and H. E. Jeffery, “Adverse neurodevelopmental outcome of infants exposed to opiate in-utero,” Early Human Development, vol. 84, no. 1, pp. 29–35, 2008.
- E. S. Bandstra, C. E. Morrow, E. Mansoor, and V. H. Accornero, “Prenatal drug exposure: infant and toddler outcomes,” Journal of Addictive Diseases, vol. 29, no. 2, pp. 245–258, 2010.
- B. M. Lester and L. L. Lagasse, “Children of addicted women,” Journal of Addictive Diseases, vol. 29, no. 2, pp. 259–276, 2010.
- S. Soepatmi, “Developmental outcomes of children of mothers dependent on heroin or heroin/methadone during pregnancy,” Acta Paediatrica, International Journal of Paediatrics, Supplement, vol. 83, no. 404, pp. 36–39, 1994.
- N. McKeganey, M. Barnard, and J. McIntosh, “Paying the price for their parents' addiction: meeting the needs of the children of drug-using parents,” Drugs, vol. 9, no. 3, pp. 233–246, 2002.
- J. Melnikow, S. A. Alemagno, C. Rottman, and S. J. Zyzanski, “Characteristics of inner-city women giving birth with little or no prenatal care: a case-control study,” Journal of Family Practice, vol. 32, no. 3, pp. 283–288, 1991.
- R. H. Kelly, B. H. Danielsen, J. M. Golding, T. F. Anders, W. M. Gilbert, and D. F. Zatzick, “Adequacy of prenatal care among women with psychiatric diagnoses giving birth in California in 1994 and 1995,” Psychiatric Services, vol. 50, no. 12, pp. 1584–1590, 1999.
- J. Hankin, M. E. McCaul, and J. Heussner, “Pregnant, alcohol-abusing women,” Alcoholism, vol. 24, no. 8, pp. 1276–1286, 2000.
- D. L. Pagnini and N. E. Reichman, “Psychosocial factors and the timing of prenatal care among women in New Jersey's HealthStart program,” Family Planning Perspectives, vol. 32, no. 2, pp. 56–64, 2000.
- R. Maupin Jr., R. Lyman, J. Fatsis et al., “Characteristics of women who deliver with no prenatal care,” Journal of Maternal-Fetal and Neonatal Medicine, vol. 16, no. 1, pp. 45–50, 2004.
- A. Bartu, J. Sharp, J. Ludlow, and D. A. Doherty, “Postnatal home visiting for illicit drug-using mothers and their infants: a randomised controlled trial,” Australian and New Zealand Journal of Obstetrics and Gynaecology, vol. 46, no. 5, pp. 419–426, 2006.
- K. J. Farkas and T. V. Parran, “Treatment of cocaine addiction during pregnancy,” Clinics in Perinatology, vol. 20, no. 1, pp. 29–46, 1993.
- M. Chaffin, K. Kelleher, and J. Hollenberg, “Onset of physical abuse and neglect: psychiatric, substance abuse, and social risk factors from prospective community data,” Child Abuse and Neglect, vol. 20, no. 3, pp. 191–203, 1996.
- P. K. Jaudes, E. Ekwo, and J. Van Voorhis, “Association of drug abuse and child abuse,” Child Abuse and Neglect, vol. 19, no. 9, pp. 1065–1075, 1995.
- P. K. Jaudes and E. E. Ekwo, “Outcomes,” Child Welfare, vol. 76, no. 4, pp. 521–534, 1997.
- P. Nair, M. M. Black, M. Schuler et al., “Risk factors for disruption in primary caregiving among infants of substance abusing women,” Child Abuse and Neglect, vol. 21, no. 11, pp. 1039–1051, 1997.
- S. E. Gutierres and C. Van Puymbroeck, “Childhood and adult violence in the lives of women who misuse substances,” Aggression and Violent Behavior, vol. 11, no. 5, pp. 497–513, 2006.
- P. Laws and E. A. Sullivan, “Australia’s mothers and babies 2007,” Perinatal Statistics Series No. 23, Cat. No. PER 48, Australian Institute of Health and Welfare, Canberra, Australia, 2009.
- C. Turner, A. Russell, and W. Brown, “Prevalence of illicit drug use in young Australian women, patterns of use and associated risk factors,” Addiction, vol. 98, no. 10, pp. 1419–1426, 2003.
- M. Scully, N. Geoghegan, P. Corcoran, M. Tiernan, and E. Keenan, “Specialized drug liaison midwife services for pregnant opioid dependent women in Dublin, Ireland,” Journal of Substance Abuse Treatment, vol. 26, no. 1, pp. 27–33, 2004.
- W. Hall and J. Hando, “Route of administration and adverse effects of amphetamine use among young adults in Sydney, Australia,” Drug and Alcohol Review, vol. 13, pp. 277–284, 1994.
- S. Darke, S. Kaye, and L. Topp, “Cocaine use in New South Wales, Australia, 1996-2000: 5 year monitoring of trends in price, purity, availability and use from the illicit drug reporting system,” Drug and Alcohol Dependence, vol. 67, no. 1, pp. 81–88, 2002.
- A. Williamson, S. Darke, J. Ross, and M. Teesson, “Cocaine use among the ATOS NSW sample: prevalence and related harms,” NDARC Technical Report 161, National Drug and Alcohol Research Centre, Sydney, Australia, 2003.
- N. Fairbairn, T. Kerr, J. A. Buxton, K. Li, J. S. Montaner, and E. Wood, “Increasing use and associated harms of crystal methamphetamine injection in a Canadian setting,” Drug and Alcohol Dependence, vol. 88, no. 2-3, pp. 313–316, 2007.
- L. B. Sloan, J. W. Gay, S. W. Snyder, and W. R. Bales, “Substance abuse during pregnancy in a rural population,” Obstetrics and Gynecology, vol. 79, no. 2, pp. 245–248, 1992.
- M. C. Freda, C. Chazotte, and J. Youchah, “What do we know about how to enroll and retain pregnant drug users in prenatal care?” Journal of Women's Health, vol. 4, no. 1, pp. 55–63, 1995.
- A. B. Berenson, G. S. Wllkinson, and L. A. Lopez, “Effects of prenatal care on neonates born to drug-using women,” Substance Use and Misuse, vol. 31, no. 8, pp. 1063–1076, 1996.
- M. P. Laken, J. F. McComish, and J. Ager, “Predictors of prenatal substance use and birth weight during outpatient treatment,” Journal of Substance Abuse Treatment, vol. 14, no. 4, pp. 359–366, 1997.
- R. M. Gabriel, F. P. Mondeaux, K. E. Laws, K. J. Hahn, and D. Weaver, “Reducing births of drug-affected babies: a retrospective analysis of archival data and a community wide effort,” Evaluation and Program Planning, vol. 23, no. 3, pp. 347–353, 2000.
- H. L. Johnson, B. J. Nusbaum, A. Bejarano, and T. S. Rosen, “An ecological approach to development in children with prenatal drug exposure,” American Journal of Orthopsychiatry, vol. 69, no. 4, pp. 448–456, 1999.
- R. S. Byrd, A. M. Neistadt, C. R. Howard, C. Brownstein-Evans, and M. Weitzman, “Why screen newborns for cocaine: service patterns and social outcomes at age one year,” Child Abuse and Neglect, vol. 23, no. 6, pp. 523–530, 1999.
- S. W. Jacobson, L. M. Chiodo, R. J. Sokol, and J. L. Jacobson, “Validity of maternal report of prenatal alcohol, cocaine, and smoking in relation to neurobehavioral outcome,” Pediatrics, vol. 109, no. 5, pp. 815–825, 2002.